Skip to main content
Clinical Trials/KCT0002345
KCT0002345Recruiting未知

A study to evaluate the validity and reliability of instrument of pattern identification for Benign Prostatic Hyperplasia and to analyze correlation between IPSS, uroflowmetry, the remaining urine amounts, sasang constitution

Dunsan Korean Medicine Hospital of Daejeon University0 sites56 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
56

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational Study

Eligibility Criteria

Ages
50(Year) to o Limit (—)
Sex
Male

Inclusion Criteria

  • Men over 50
  • -Complaints of lower urinary tract symptoms, which refer to storage symptoms(urine frequency more than 8 times a day, nocturia, urgency) and voiding symptoms(hesitancy, intermittency, straining)
  • -Ultrasonically sized prostate larger than 25g or diagnosed with benign prostatic hyperplasia

Exclusion Criteria

  • -Prostate cancer, prostatitis syndrome, bladder tumor, urinary stone, urethral stricture, bladder neck structure, lower urinary tract (bladder, urethral) inflammation, urinary tuberculosis
  • -Diagnosed as a neurogenic bladder due to cerebrovascular disease, brain tumor, cerebral palsy, Parkinson's disease, multiple system atrophy, multiple sclerosis, spinal cord injury, autonomic nerve hyperreflexia, spinal cord dysplasia, pelvic surgery, herpes virus infection or diabetes
  • - Prostate specific antigen level = 10 ng / mL
  • - A man who refuse to accept participation in research
  • - A person who is considered to be ineligible for participation in clinical trials due to the test result or other reasons

Investigators

Sponsor
Dunsan Korean Medicine Hospital of Daejeon University

Similar Trials